Key Details
Price
$50.70Last Dividend
$0.87TTM Dividend Yield
1.72%PE Ratio
15.57Annual ROE
6.04%Beta
0.37Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Oct 31, 2024Recent annual earnings:
Feb 29, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
May 3, 2024Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Events
Dividend per share
Dividend yield
Other
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Anheuser-Busch InBev's stock has not performed well for investors in recent years. However, after maintaining a 'Sell' rating for a long time, I now believe that BUD might provide good returns for shareholders. I will examine the company's pricing and the positive changes happening in the business, which support my decision to give it a 'Buy' rating.
The two sectors might be doing quite well. Although most S&P 500 stocks were down on Monday, these two sectors showed slight gains.
We believe that Anheuser-Busch InBev stock (NYSE: BUD) is a more attractive option compared to Diageo stock (NYSE: DEO) right now. BUD is valued at 1.6 times its past revenues, while DEO is at 3.3 times.
Anheuser-Busch is boosting its investment in Super Bowl LIX, bringing back its famous brands, star power, and the unforgettable stories that fans love. For many years, Anheuser-Busch brands have been part of the most memorable moments in sports and entertainment.
BUD is struggling to gain positive support due to challenges like currency devaluation, a drop in alcohol sales compared to last year, and possible cancer warnings. The overall decline in the industry may be linked to the increasing popularity of cannabis and a rising interest in healthier, non-alcoholic options. However, BUD has shown a steady increase in sales volumes since the first quarter of 2024, and its growing adjusted EBITDA highlights a potential recovery.
AB InBev has teamed up with Pabst to produce beer at its breweries. This is an important move for AB InBev as it brings a previous rival into its supply chain.
In 2023, Americans drank more than 62 million cases of ready-to-drink spirits, which is nearly a 25% rise compared to 2022.
BUD stock is still falling because of ongoing cost challenges. Nevertheless, the company's emphasis on premium products and the Beyond Beer range could lead to future growth.
India's antitrust agency has conducted searches at the offices of major alcohol companies Pernod Ricard and Anheuser-Busch InBev. This action is part of an investigation into claims that they may have colluded with retailers to fix prices in a southern state, according to sources who are knowledgeable about the situation.
We have just put together a list of the 10 global stocks that are currently oversold and worth buying. In this article, we will examine how Anheuser-Busch InBev SA/NV (NYSE:BUD) compares to the other oversold stocks. The saying, "There are decades where nothing happens, and there are weeks where decades happen," is a fitting way to begin this discussion.
FAQ
- What is the ticker symbol for Anheuser-Busch InBev SA/NV?
- Does Anheuser-Busch InBev SA/NV pay dividends?
- What sector is Anheuser-Busch InBev SA/NV in?
- What industry is Anheuser-Busch InBev SA/NV in?
- What country is Anheuser-Busch InBev SA/NV based in?
- When did Anheuser-Busch InBev SA/NV go public?
- Is Anheuser-Busch InBev SA/NV in the S&P 500?
- Is Anheuser-Busch InBev SA/NV in the NASDAQ 100?
- Is Anheuser-Busch InBev SA/NV in the Dow Jones?
- When was Anheuser-Busch InBev SA/NV's last earnings report?
- When does Anheuser-Busch InBev SA/NV report earnings?
- Should I buy Anheuser-Busch InBev SA/NV stock now?